Slingshot members are tracking this event:
FDA Priority Review date for Venetoclax Set mid-2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Apr 11, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Venetoclax, Chronic Lymphocytic Leukemia, Bcl-2 Inhibitor, 17p Deletion, B-cell Lymphoma-2